Lacklustre Performance Is Driving Immunocore Holdings Plc's (NASDAQ:IMCR) 31% Price Drop

Unfortunately for some shareholders, the Immunocore Holdings plc (NASDAQ:IMCR) share price has dived 31% in the last thirty days, prolonging recent pain. Instead of being rewarded, shareholders who

Simply Wall StJun 19 02:53

Express News | Immunocore Announces Randomization of First Patient in the Global, Registrational Phase 3 Clinical Trial Testing Brenetafusp for the Treatment of First-Line Advanced or Metastatic Cutaneous Melanoma

BreakingsJun 18 19:00

Is Immunocore Holdings (NASDAQ:IMCR) Using Debt Sensibly?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only n

Simply Wall StJun 15 21:24

HC Wainwright & Co. Reiterates Buy on Immunocore Hldgs, Maintains $100 Price Target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs with a Buy and maintains $100 price target.

Analyst UpgradesJun 5 23:35

H.C. Wainwright Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $100

H.C. Wainwright analyst Patrick Trucchio maintains $Immunocore(IMCR.US)$ with a buy rating, and maintains the target price at $100.According to TipRanks data, the analyst has a success rate of 28.9% a

Futu NewsJun 5 23:32

A Quick Look at Today's Ratings for Immunocore(IMCR.US), With a Forecast Between $81 to $92

On Jun 04, major Wall Street analysts update their ratings for $Immunocore(IMCR.US)$, with price targets ranging from $81 to $92.Goldman Sachs analyst Rajan Sharma maintains with a buy rating.Barclays

Futu NewsJun 4 21:00